|
Name: Dioxaphetyl butyrate
Type: Hallucinogen
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Dioxaphetyl butyrate, a synthetic compound, was developed for research purposes. It is studied for its effects on the central nervous system and potential applications in medicine.
|
|
V. Legal Information
Dioxaphetyl butyrate, an opioid analgesic, is classified as a Schedule I substance in the US, making it illegal. Its high potential for abuse and lack of accepted medical use lead to similar bans in many countries. The UNODC and other regulatory bodies emphasize strict control measures to prevent misuse and address the opioid crisis.
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Dioxaphetyl butyrate is a synthetic compound with limited clinical use. It can cause sedation and impair motor function. Short-term use may be effective in specific medical conditions, but long-term use poses risks of dependence and cognitive impairment. Overdose risks include severe sedation and respiratory depression. Safe use involves precise dosing and medical supervision. Recent research focuses on its pharmacological effects and safety profile.  |
|
VII. Psychological Effects
Dioxaphetyl butyrate, a synthetic opioid, affects mu-opioid receptors, leading to significant euphoria and sedation. Immediate effects include mood elevation and pain relief, lasting several hours. Long-term use may result in addiction, cognitive impairments, and mood disturbances. Research highlights its potent effects and risks associated with opioid receptor interactions and psychological dependence.
 |
|
VIII. Culture
Dioxaphetyl butyrate is a synthetic opioid analgesic providing pain relief, classifying it as a downer. Short-term use alleviates severe pain, while long-term use can lead to dependence and tolerance. Overdose is highly possible, causing respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 100 mg per day. Recent research highlights its efficacy in pain management but warns of addiction risks. Physical effects include drowsiness, constricted pupils, and respiratory depression.
 |